DrugPatentWatch Database Preview
Details for Biologics License Application: 101134
» See Plans and Pricing
Summary for BLA: 101134
| Tradename: | GAMASTAN |
| Applicant: | Grifols Usa, Llc |
| Ingredient: | immune globulin (human) |
| Patents: | 4 |
| Approval Date: | Aug 14, 1996 |
| Suppliers: see list | 1 |
US Patents for BLA: 101134
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grifols Usa, Llc | GAMASTAN | immune globulin (human) | INJECTION, SOLUTION | 101134 | 1 | 1996-08-14 | Start Trial | Halozyme, Inc. (San Diego, CA) | 2023-03-05 | search | ||
| Grifols Usa, Llc | GAMASTAN | immune globulin (human) | INJECTION, SOLUTION | 101134 | 1 | 1996-08-14 | Start Trial | The Australian National University (Acton, AU) | 2008-09-24 | search | ||
| Grifols Usa, Llc | GAMASTAN | immune globulin (human) | INJECTION, SOLUTION | 101134 | 1 | 1996-08-14 | Start Trial | Acambis, Inc. (Cambridge, MA) | 2017-10-20 | search | ||
| Grifols Usa, Llc | GAMASTAN | immune globulin (human) | INJECTION, SOLUTION | 101134 | 1 | 1996-08-14 | Start Trial | Gilead Sciences, Inc. (Foster City, CA) | 2027-07-06 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
